APS Support UK/X
Aug 7, 2025, 00:59
Hydroxychloroquine in APS: Anti-Inflammatory and Antithrombotic Effects Supported by Recent Evidence
APS Support UK has shared a post on X:
“ NEW REVIEW | Hydroxychloroquine in APS
- HCQ shows anti-inflammatory/thrombotic effects
- Deacreases platelet aggregation, NET formation, complement (C3a/C5a)
- Supports use in OAPS ( higher birth rate in treated vs untreated: 67% vs 57%).”
Read the full article here.
Title: The Role of Hydroxychloroquine in the Management of Rheumatic Disorders: A Comprehensive Review
Authors: Ilker Ates, Hilal Sahin, Lalu Muhammad Irham, Serkan Yilmaz, Sinan Suzen
Stay updated with the latest scientific advances with Hemostasis Today.
-
Nov 10, 2025, 10:16Pablo Corral on Enlicitide: The Phase 3 CORALreef HeFH Trial Brings a Major Step Forward
-
Nov 10, 2025, 10:15Laurent Bertoletti Invites You to the Joint INNOVTE and GITA Meeting on Hormones and Thrombosis
-
Nov 10, 2025, 10:15Christopher Cannon: DOAC Monotherapy Wins Again
-
Nov 10, 2025, 10:14Marieke Kruip on Sex differences in Outcomes of VKA Treatment in Patients with Mechanical Heart Valve
-
Nov 10, 2025, 10:14Ana Paula Lacombe: From Research to Bedside, Innovation in Stroke Care is Moving Fast!
-
Nov 10, 2025, 10:13Jan Sloves: Understanding Iliofemoral DVT – What You Can’t Afford to Miss
-
Nov 10, 2025, 10:12Mohamed Rawy Shares a Comprehensive Guide For Anticoagulation
-
Nov 10, 2025, 10:10Marc Carrier: Proud to Share the Results of the WAVe Study
-
Nov 10, 2025, 10:07Frederik Denorme – The New PI at the Laboratory of Cell Biology and Histology at University of Antwerp